Co-Authors
This is a "connection" page, showing publications co-authored by BETH CHASEN and S CHEENU KAPPADATH.
Connection Strength
0.333
-
Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients. J Hepatocell Carcinoma. 2020; 7:117-131.
Score: 0.187
-
A CT acquisition technique to generate images at various dose levels for prospective dose reduction studies. AJR Am J Roentgenol. 2011 Feb; 196(2):W144-51.
Score: 0.096
-
A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021; 8:1129-1145.
Score: 0.050